RMRiccardo Maragna

Riccardo Maragna

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Riccardo Maragna has a total of 136 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    New cardiovascular risk factor and clinical surrogate: epicardial fat

    by Saima Mushtaq, Maria Elisabetta Mancini, Riccardo Maragna, Ettore Ventura, Gianluca Pontone

    Coronary computed tomography angiography (CCTA) has become a cornerstone in the non-invasive evaluation of coronary artery disease (CAD). Beyond defining stenosis severity, CCTA enables detailed quantification of total atherosclerotic burden, plaque composition, and imaging markers of plaque vulnerability. Recent advances—including artificial intelligence (AI)-enhanced algorithms—now allow automated and highly reproducible plaque phenotyping, with major implications for risk stratification and therapeutic monitoring. Concurrently, imaging of pericoronary adipose tissue has introduced novel biomarkers of vascular inflammation, particularly the Fat Attenuation Index and pericoronary adipose tissue attenuation. These indices independently predict adverse cardiovascular events beyond traditional risk factors. Serial imaging studies further demonstrate that lipid-lowering and anti-inflammatory therapies modulate plaque biology, promoting regression or stabilization. Integration of coronary plaque analytics, adipose tissue biology, and AI-driven risk prediction is redefining preventive cardiology and enabling increasingly individualized management strategies.


  • Open Access

    Don't raise your white flag facing a sea of red ones: when cardiac amyloidosis mimics hypertrophic cardiomyopathy

    by Giulia Grilli, Massimo Mapelli, Luigi Tassetti, Mauro Contini, Andrea Baggiano, Sebastiano Gili, Alberico Del Torto, Riccardo Maragna, Fabrizio Celeste, Gianfranco Sinagra, et al.

    Cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) present significant diagnostic challenges due to their phenotypic overlap, with both conditions commonly manifesting as increased ventricular wall thickness and diastolic dysfunction. Accurate differentiation is critical as prognostic implications and therapeutic strategies differ significantly. We describe the case of a 65-year-old male initially diagnosed with non-obstructive HCM, presenting with syncope and exercise-induced non-sustained ventricular tachycardia (NSVT). Despite a confounding clinical presentation mimicking classical sarcomeric HCM, a systematic diagnostic evaluation revealed key "red flag" features including low-voltage ECG findings, pseudonecrosis, and a history of bilateral carpal tunnel surgery, raising suspicion of infiltrative cardiomyopathy. Further investigations, including cardiac magnetic resonance imaging, demonstrated diffuse subendocardial late gadolinium enhancement and elevated T1/T2 mapping values, strongly suggestive of CA. Technetium-99m scintigraphy confirmed transthyretin amyloidosis (ATTR), and genetic testing excluded pathogenic variants associated with sarcomeric HCM and hereditary ATTR. Targeted therapy with tafamidis and a mineralocorticoid receptor antagonist was initiated, while the initial indication for implantable cardioverter-defibrillator implantation was reconsidered based on the updated diagnosis and current guidelines. At 18-month follow-up, the patient remains clinically stable, with preserved functional capacity, normal NT-proBNP levels, and no adverse events. This case underscores the importance of a systematic diagnostic approach in differentiating CA from HCM, particularly in the presence of characteristic clinical and imaging findings. Early recognition and treatment of CA with disease-modifying therapies can alter its trajectory, highlighting the need for increased clinical suspicion and integration of advanced diagnostic modalities in similar cases.

  • Resource and OUTcome Impact of routiNE availability of Computed Tomography Perfusion

    by Andrea Baggiano, Riccardo Maragna, Saima Mushtaq, Andrea Annoni, Giovanni Berna, Francesco Cannata, Alberico Del Torto, Maria Ludovica Carerj, Fabio Fazzari, Alberto Formenti, et al.

    Aims: Stress computed tomography perfusion (Stress-CTP) is a functional technique added on top of coronary computed tomography angiography (cCTA) to improve the management of subjects with coronary artery disease (CAD). The ROUTINE-CTP Registry is a prospective study aimed at evaluating the impact of routine implementation of combined cCTA plus Stress-CTP for the assessment of patients with intermediate to high CAD risk or known CAD symptomatic for chest pain in a real-world setting. Methods and results: Data collected during follow-up included radiation exposure, reclassification rates between cCTA alone and cCTA with Stress-CTP, subsequent non-invasive testing, referral rates for invasive coronary angiography (ICA), prevalence of non-obstructive CAD at ICA, rates of revascularization, and major adverse cardiac events (MACE). Two hundred and sixty-three consecutive patients participated in the study (mean age of 65 ± 9 years, 79% male), of whom 156 (59%) had undergone previous revascularization. The evaluability rates for cCTA and Stress-CTP were 95 and 99%, respectively. Patients with functionally significant CAD experienced more downstream invasive testing and revascularization (P < 0.001), inducible ischaemia resulted the main independent predictor of revascularization (heart rate 20.08), and no coronary-related MACE occurred in the subset of patients with obstructive CAD and the absence of inducible ischaemia. Conclusion: The presence of inducible ischaemia at stress-CTP resulted the main predictor of coronary revascularization, while the absence of perfusion defects allowed to safely deferred further testing or invasive evaluation. This approach demonstrated a higher diagnostic yield in identifying individuals at lower risk of adverse events despite the presence of obstructive CAD.


  • Open Access

    Valve type and post-dilation impact on transprosthetic gradients in patients undergoing transcatheter aortic valve-in-valve procedure

    by Manuela Muratori, Laura Fusini, Gloria Tamborini, Paola Gripari, Sarah Ghulam Ali, Valentina Mantegazza, Anna Garlaschè, Francesco Doni, Andrea Baggiano, Francesco Cannata, et al.

    Aims: Valve-in-Valve transcatheter aortic valve replacement (ViV-TAVR) is an appealing treatment option for patients with degenerated aortic bioprosthetic valves. However, higher post-procedural transprosthetic gradients are more common after ViV-TAVR than after TAVR for native aortic valve stenosis. We sought to evaluate the impact of type of implanted valve and balloon post-dilation on echocardiographic results and mortality in ViV-TAVR patients. Methods and results: One hundred and eleven consecutive patients were enrolled. A balloon-expandable valve, a self-expandable valve without balloon post-dilation, and a self-expandable valve with balloon post-dilation were performed in 35 (Group 1), 39 (Group 2), and 37 (Group 3) patients, respectively. All patients underwent comprehensive transthoracic echocardiography at baseline, discharge, and 6–12 months follow-up. Successful ViV-TAVR was performed in 110 patients (99%). Baseline transprosthetic gradients, left ventricular volumes, ejection fraction, and pulmonary artery systolic pressure were similar among groups. All groups experienced a significant reduction in post-procedural gradients at discharge and during the 6–12 months follow-up compared with baseline. At discharge, the lowest mean gradient was observed in Group 3 (12 ± 7 mmHg) compared with both Group 1 (20 ± 9 mmHg) and Group 2 (17 ± 8 mmHg, P = 0.001). This result was confirmed at 6–12 months follow-up (P = 0.012). Similar 5-year all-cause mortality was observed among groups (34%, 36%, 14%, respectively, P = 0.056). Conclusion: In patients with failed surgical aortic prosthesis, ViV-TAVR is an effective treatment option associated with sustained improved haemodynamics regardless of transcatheter valve type and use of balloon post-dilation. However, self-expandable valves with balloon post-dilation showed lower transprosthetic gradients.


  • Open Access

    An automated and time-efficient framework for simulation of coronary blood flow under steady and pulsatile conditions

    by Guido Nannini, Simone Saitta, Luca Mariani, Riccardo Maragna, Andrea Baggiano, Saima Mushtaq, Gianluca Pontone, Alberto Redaelli


  • STress computed tomogRaphy perfusion and stress cArdiac magnetic resonance for ThE manaGement of suspected or known coronarY artery disease: resources and outcomes impact

    by Andrea Baggiano, Francesca Baessato, Saima Mushtaq, Andrea Daniele Annoni, Francesco Cannata, Maria Ludovica Carerj, Alberico Del Torto, Fabio Fazzari, Alberto Formenti, Antonio Frappampina, et al.

  • Open Access

    A Novel Data Augmentation Method for Radiomics Analysis Using Image Perturbations

    by F Lo Iacono, R. Maragna, G. Pontone, V. D. A. Corino

    Radiomics extracts hundreds of features from medical images to quantitively characterize a region of interest (ROI). When applying radiomics, imbalanced or small dataset issues are commonly addressed using under or over-sampling, the latter being applied directly to the extracted features. Aim of this study is to propose a novel balancing and data augmentation technique by applying perturbations (erosion, dilation, contour randomization) to the ROI in cardiac computed tomography images. From the perturbed ROIs, radiomic features are extracted, thus creating additional samples. This approach was tested addressing the clinical problem of distinguishing cardiac amyloidosis (CA) from aortic stenosis (AS) and hypertrophic cardiomyopathy (HCM). Twenty-one CA, thirty-two AS and twenty-one HCM patients were included in the study. From each original and perturbed ROI, 107 radiomic features were extracted. The CA-AS dataset was balanced using the perturbation-based method along with random over-sampling, adaptive synthetic (ADASYN) and the synthetic minority oversampling technique (SMOTE). The same methods were tested to perform data augmentation dealing with CA and HCM. Features were submitted to robustness, redundancy, and relevance analysis testing five feature selection methods (p-value, least absolute shrinkage and selection operator (LASSO), semi-supervised LASSO, principal component analysis (PCA), semi-supervised PCA). Support vector machine performed the classification tasks, and its performance were evaluated by means of a 10-fold cross-validation. The perturbation-based approach provided the best performances in terms of f1 score and balanced accuracy in both CA-AS (f1 score: 80%, AUC: 0.91) and CA-HCM (f1 score: 86%, AUC: 0.92) classifications. These results suggest that ROI perturbations represent a powerful approach to address both data balancing and augmentation issues.


  • Open Access

    A fully automated deep learning approach for coronary artery segmentation and comprehensive characterization

    by Guido Nannini, Simone Saitta, Andrea Baggiano, Riccardo Maragna, Saima Mushtaq, Gianluca Pontone, Alberto Redaelli

    Coronary computed tomography angiography (CCTA) allows detailed assessment of early markers associated with coronary artery disease (CAD), such as coronary artery calcium (CAC) and tortuosity (CorT). However, their analysis can be time-demanding and biased. We present a fully automated pipeline that performs (i) coronary artery segmentation and (ii) CAC and CorT objective analysis. Our method exploits supervised learning for the segmentation of the lumen, and then, CAC and CorT are automatically quantified. 281 manually annotated CCTA images were used to train a two-stage U-Net-based architecture. The first stage employed a 2.5D U-Net trained on axial, coronal, and sagittal slices for preliminary segmentation, while the second stage utilized a multichannel 3D U-Net for refinement. Then, a geometric post-processing was implemented: vessel centerlines were extracted, and tortuosity score was quantified as the count of branches with three or more bends with change in direction forming an angle >45°. CAC scoring relied on image attenuation. CAC was detected by setting a patient specific threshold, then a region growing algorithm was applied for refinement. The application of the complete pipeline required <5 min per patient. The model trained for coronary segmentation yielded a Dice score of 0.896 and a mean surface distance of 1.027 mm compared to the reference ground truth. Tracts that presented stenosis were correctly segmented. The vessel tortuosity significantly increased locally, moving from proximal, to distal regions (p < 0.001). Calcium volume score exhibited an opposite trend (p < 0.001), with larger plaques in the proximal regions. Volume score was lower in patients with a higher tortuosity score (p < 0.001). Our results suggest a linked negative correlation between tortuosity and calcific plaque formation. We implemented a fast and objective tool, suitable for population studies, that can help clinician in the quantification of CAC and various coronary morphological parameters, which is helpful for CAD risk assessment.


  • Open Access

    P72 A CASE OF DRAMATIC HEART CHAMBERS REVERSE REMODELING AND DISEASE REGRESSION IN A PATIENT WITH HEART FAILURE AND END–STAGE RENAL FAILURE TREATED WITH SACUBITRIL/VALSARTAN AND SGLT2I: THE IMPORTANCE OF PUSHING THE BOUNDARIES

    by M Mapelli, V Mantegazza, C Ferrari, R Cimino, R Maragna, G Pontone, P Palermo, N Amelotti, S Matteo, M Pepi, et al.

    Heart failure (HF) therapy has been disrupted by the introduction of 2 new prognostic–relevant drugs: Sacubitril/Valsartan and SGLT2i. However, the amount of evidence for guideline–directed HF therapies in the context of chronic kidney disease (CKD) is relatively modest, especially in advanced stages (e.g., on haemodialysis). Aim of this report is to describe the feasibility and the efficacy of HF medical therapy in a patient with naive HFrEF and CKD on haemodialysis. Case report: A woman in her 40’s, with no cardiovascular history, affected by polycystic kidney disease end end–stage CKD placed on hemodialysis for the previous 9 months, underwent a echocardiography (TTE) in 09/2021, as part of investigations for kidney transplantation. The TTE showed a picture consistent with dilated cardiomyopathy with reduced EF, severe left atrium (LA) dilation and moderate–to–severe mitral regurgitation (MR). Thus, the patient was temporarily suspended from the transplant list. She was on chronic diuretic therapy with high dose of furosemide (250mg b.i.d.), with a residual diuresis of 400–500 mL per day. An elective coronary angiography showed normal coronary arteries. A Cardiac Magnetic Resonance (CMR) confirmed the diagnosis of DCM with severe dilation of the left ventricle (LV), reduced EF and severe MR. A cardiopulmonary exercise test (CPET) showed mild functional limitation with no pulmonary vascular limitation. After a multidisciplinary evaluation involving HF specialists and nephrologists, the recommended quadruple HF therapy was started and gradually up–titrated during the following 10 months. Neither the hemodialysis protocol nor the diuretic therapy was changed throughout this period. No adverse events were observed (e.g., increased sessions or dialysis schedule, hyperkalemia, hypotension). During this timeframe, the patients was asymptomatic and a progressive and sustained decrease in N–terminal pro B–type natriuretic peptide (NT–proBNP) from 26356 to 1556 ng/ml was observed. We documented a significant amelioration in CPET and other laboratory parameters (sST2), as well as a consistent reverse remodeling of the left heart chambers and a significant reduction in MR grade.

  • Quantification of extracellular volume with cardiac computed tomography in patients with dilated cardiomyopathy

    by Andrea Baggiano, Edoardo Conte, Luigi Spiritigliozzi, Saima Mushtaq, Andrea Annoni, Maria Ludovica Carerj, Francesco Cilia, Fabio Fazzari, Alberto Formenti, Antonio Frappampina, et al.